查詢結果分析
相關文獻
頁籤選單縮合
題名 | The Prognostic Value of Circumferential Resection Margin in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiation Therapy and Surgery |
---|---|
作者姓名(外文) | Liu, Chao-yu; Wang, Bing-yen; Lee, Ming-yuan; Tsai, Yu-chen; Liu, Chia-chuan; Shih, Chih-hsun; | 書刊名 | Journal of the Chinese Medical Association |
卷期 | 76:10 2013.10[民102.10] |
頁次 | 頁570-575 |
分類號 | 415.512 |
關鍵詞 | Circumferential resection margin; Concurrent chemoradiation therapy; Esophageal squamous cell carcinoma; |
語文 | 英文(English) |
英文摘要 | Background: Despite the significant advances in surgical techniques and multimodality treatments for esophageal cancer, the overall survival remains unsatisfactory. During the past years, efforts were made to determine the prognostic factors that would help in identifying patients suitable for surgery or guiding adjuvant therapy. Positive circumferential resection margins (CRMs) in esophageal cancer have been previously linked with poor prognosis, but their impact on survival remains controversial in patients treated by a multimodality protocol. The aim of our study was to examine the significance of tumor involvement of CRM in patients with esophageal squamous cell carcinoma after concurrent chemoradiation therapy followed by esophagectomy. Methods: Between 2000 and 2010, 94 esophageal squamous cell carcinoma patients who received preoperative concurrent chemoradiation therapy followed by surgery were enrolled in our study. We focused on the CRM, which was defined microscopically as clear (negative) or involved (positive). Univariate and multivariate survival analyses were performed with overall survival as the endpoint. Results: Our cohort was predominantly male (94.7%) with a median age of 57 years. All of them received concurrent chemoradiation therapy followed by esophagectomy. Overall, 17 patients (18.1%) had positive CRM. KaplaneMeier survival analysis demonstrated that the 5-year overall survival of patients with clear and involved CRM is 60.1% and 11.8%, respectively (log rank p < 0.001). Multivariate analysis with the Cox proportional hazard model demonstrated that CRM involvement is a significant prognostic factor for overall survival ( p < 0.001). Conclusion: In patients with esophageal squamous cell carcinoma who underwent trimodality treatment, CRM involvement is a significant risk factor predicting survival. Additional effort is required to achieve a clear CRM in esophageal cancer treatment. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。